Copyright
©The Author(s) 2024.
World J Virol. Sep 25, 2024; 13(3): 95349
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.95349
Published online Sep 25, 2024. doi: 10.5501/wjv.v13.i3.95349
Table 3 Effect of vitamin D levels on viral infections according to age, gender and systemic conditions
Ref. | Age group | Gender | Preexisting conditions | Results |
Martineau et al[43], 2017 | 0–95 yr | Both genders | Asthma, COPD | Vitamin D supplementation is effective in reducing the risk of acute respiratory infections |
Ginde et al[9], 2009 | ≥ 20 yr | Both genders | Chronic diseases (DM, HT) | Vitamin D deficiency is associated with the prevalence of upper respiratory tract infections |
Sabetta et al[44], 2010 | 20–89 yr | Both genders | Chronic diseases | The risk of respiratory tract infection is reduced in individuals with serum 25(OH)D levels above 38 ng/mL |
Cannell et al[7], 2006 | 0–90 yr | Both genders | Various health conditions | Vitamin D deficiency may increase susceptibility to influenza and respiratory infections |
Laaksi et al[45], 2007 | 18–28 yr | Male | Healthy individuals | Vitamin D supplementation may reduce incidence of respiratory infections |
Urashima et al[46], 2010 | 6–15 yr | Both genders | Healthy children | Vitamin D supplementation is effective in reducing the incidence of influenza A |
Berry et al[47], 2011 | ≥ 65 yr | Both genders | Chronic diseases | Vitamin D deficiency is associated with risk of respiratory infections |
Murdoch et al[48], 2012 | 50–84 yr | Both genders | Chronic diseases (COPD) | Vitamin D supplementation has no protective effect on respiratory infections |
Jolliffe et al[49], 2020 | 0–95 yr | Both genders | Asthma, COPD | Vitamin D supplementation is effective in reducing the risk of acute respiratory infections |
Camargo et al[50], 2012 | 3–24 yr | Both genders | Healthy children | Vitamin D deficiency may increase risk of acute lower respiratory tract infections |
Hollams et al[51], 2011 | 0–10 yr | Both genders | Asthma, allergy | Vitamin D deficiency is associated with asthma and respiratory infections |
Majak et al[52], 2011 | 5–18 yr | Both genders | Asthma | Vitamin D supplementation may reduce infection frequency in children with asthma |
Esposito et al[53], 2013 | 0–16 yr | Both genders | Healthy children | Vitamin D deficiency may increase risk of respiratory infections |
Thornton et al[54], 2014 | 18–45 yr | Both genders | HIV positive individuals | Vitamin D deficiency is associated with risk of respiratory infections |
Belderbos et al[55], 2011 | 0–1 yr | Both genders | Healthy babies | Vitamin D deficiency may increase the risk of respiratory syncytial virus bronchiolitis |
McNally et al[56], 2009 | 0–17 yr | Both genders | Chronic diseases | Vitamin D deficiency associated with respiratory tract infection in intensive care |
Le Goaziou et al[57], 2011 | 0–16 yr | Both genders | Healthy children | Vitamin D deficiency is associated with risk of upper respiratory tract infections |
Liu et al[58], 2020 | 0–18 yr | Both genders | Chronic diseases (asthma, COPD) | Vitamin D deficiency associated with risk of viral respiratory infections |
Grant et al[59], 2009 | 0–95 yr | Both genders | Various health conditions | Vitamin D deficiency may increase risk of influenza and pneumonia |
Aloia et al[60], 2007 | 18–45 yr | Both genders | HIV positive individuals | Vitamin D deficiency is associated with risk of respiratory infections |
- Citation: Engin MMN, Özdemir Ö. Role of vitamin D in COVID-19 and other viral infections. World J Virol 2024; 13(3): 95349
- URL: https://www.wjgnet.com/2220-3249/full/v13/i3/95349.htm
- DOI: https://dx.doi.org/10.5501/wjv.v13.i3.95349